Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL
Official Title: Effects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus - A Pilot Study
Brief Summary:
This is a randomized, double-blind, placebo-controlled crossover pilot study of single-dose intranasal oxytocin (4 IU and 24 IU) in 18-60-year-old men and women with central diabetes insipidus to evaluate the effect of oxytocin on anxiety, depression and socioemotional functioning.
Following a screening visit to determine eligibility, participants will return for three main study visits.
During the main study visits, study participants will receive either oxytocin or placebo, followed by assessments of emotional behavior.
Thirty participants will be equally randomized to one of six possible drug orders: